CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 434 enrolled
Drug / intervention
BLI801 Laxative +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02822508
NCT02822508Phase 3Completed
CompareCT.gov

A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

Braintree Laboratories·interventional·Posted Jul 4, 2016·Updated Nov 7, 2023

In Brief

A Phase 3 clinical trial evaluating BLI801 Laxative and BLI801 Placebo for Constipation. Completed, enrolled 434 participants across 73 sites.

Detailed Summary

The objective of this study is to evaluate multiple doses of BLI801 Laxative for safety and efficacy versus placebo in adults experiencing non-idiopathic constipation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConstipation
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2017201820192020202120222023202420252026
First PostedJul 4, 2016
Enrollment StartJun 1, 2016
Primary CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.0 years ago

Interventions

BLI801 Laxativedrug

BLI801 oral laxative

BLI801 Placebodrug

BLI801 oral laxative placebo